ClinVar Miner

Submissions for variant NM_001002295.2(GATA3):c.708dup (p.Ser237fs)

dbSNP: rs771019738
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001254692 SCV001430755 pathogenic Hypoparathyroidism, deafness, renal disease syndrome 2020-05-28 criteria provided, single submitter research The heterozygous p.Ser237GlnfsTer variant in GATA3 was identified by our study in 1 individual with hypoparathyroidism-deafness-renal disease syndrome (HDR syndrome). Trio exome analysis showed this variant to be de novo. The p.Ser237Glnfs variant in GATA3 has been reported in 2 Japanese and 1 European (non-Finnish) individual with HDR Syndrome (PMID: 30143558, 30396722), and data from large population studies is insufficient to assess the frequency of this variant. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 237 and leads to a premature termination codon 67 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. While there is some evidence to suggest that heterozygous loss of function of the GATA3 gene is a disease mechanism in HDR Syndrome, this association is not yet strongly established based on the criteria laid out in Tayoun, 2018 (PMID: 30192042). In summary, this variant meets criteria to be classified as pathogenic for HDR Syndrome in an autosomal dominant manner based on predicted loss of function of the gene and de novo occurrence of the variant in an affected individual. ACMG/AMP Criteria applied: PVS1_strong, PS2, PS4_supporting (Richards 2015).
Invitae RCV002570570 SCV003441477 pathogenic not provided 2022-05-01 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ser237Glnfs*67) in the GATA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GATA3 are known to be pathogenic (PMID: 14985365, 21242646). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with GATA3-related conditions (PMID: 30396722, 33120464). ClinVar contains an entry for this variant (Variation ID: 977148). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.